Medically Reviewed by Neha Pathak, MD on August 08, 2025

ATTR-CM Treatment Talk

Meet Your Guide
photo of hero image
Gregory Patterson
Advocate

Gregory Patterson, 68, was diagnosed with ATTR-CM in May 2021 and has had several cardiac procedures, including the implantation of a cardiac defibrillator (ICD). He is now a passionate advocate for all things related to ATTR-CM and is involved in the Amyloid Speakers Bureau as a way to spread awareness of the condition. A retired substitute teacher, Patterson lives in the Twin Cities, MN.

Show Sources

SOURCES:

Gregory Patterson, ATTR-CM advocate, Twin Cities, Minnesota.

Cleveland Clinic: "Living With ATTR-CM: Coping and Expectations."

Institute for Clinical and Economic Review: "Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatments for Transthyretin Amyloid Cardiomyopathy."

Frontiers in Psychology: "Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis."

Medscape: "Transthyretin-Related Amyloidosis Treatment & Management: Approach Considerations, Medical Care, Surgical Care."

American Heart Association: "Transthyretin Amyloid Cardiomyopathy (ATTR-CM)."

View privacy policy and trust info

See More on Heart Disease From WebMD

Go Now